Stanford University School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

    Nature Communications

2023

  1. Assessing the usefulness of randomised trials in obstetrics and gynaecology

    BJOG: An International Journal of Obstetrics and Gynaecology

2021

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)

    Nature Communications

  2. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Methods used to assess outcome consistency in clinical studies: A literature-based evaluation

    PLoS ONE, Vol. 15, Núm. 7 July 2020

2016

  1. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

    Nature Communications, Vol. 7

  2. Prediction models in obstetrics: understanding the treatment paradox and potential solutions to the threat it poses

    BJOG: An International Journal of Obstetrics and Gynaecology

  3. Prognostic models in obstetrics: Available, but far from applicable

    American Journal of Obstetrics and Gynecology, Vol. 214, Núm. 1, pp. 79-90.e36